<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In order to improve the cytomorphologic diagnosis of malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> on lymph node fine-needle <z:hpo ids='HP_0002835'>aspiration</z:hpo> (FNA), and to make a confident discrimination between low-grade follicular non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) and <z:mp ids='MP_0000688'>lymphoid hyperplasia</z:mp>, polymerase chain reaction (PCR) analysis was performed of the Ig CDR3 region and BCL2 breakpoint region in 25 nonselected cases of malignant <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (17 NHL and 8 Hodgkin's disease [<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>]) with histologic control, and 22 cases of lymph nodal <z:mpath ids='MPATH_134'>hyperplasia</z:mpath> with histologic and/or clinical control </plain></SENT>
<SENT sid="1" pm="."><plain>Among <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, IgH monoclonality was detected in 7 (77%) of 9 NHLs and BCL2 rearrangement in 3 (17.6%) of 17 NHLs, <z:hpo ids='HP_0000001'>all</z:hpo> of which were follicular <z:e sem="disease" ids="C1516391" disease_type="Neoplastic Process" abbrv="">centroblastic</z:e>-centrocytic (FCBCC) </plain></SENT>
<SENT sid="2" pm="."><plain>Three BCL2/JH negative FCBCC cases were monoclonal for CDR3 </plain></SENT>
<SENT sid="3" pm="."><plain>Neither IgH monoclonality nor BCL2 rearrangement were found in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Among cytologically diagnosed <z:mp ids='MP_0000688'>lymphoid hyperplasias</z:mp>, one IgH polyclonal case was considered false-negative, being histologically diagnosed as lymphoplasmacytic NHL on the subsequent excisional biopsy </plain></SENT>
<SENT sid="5" pm="."><plain>Another 4 cases (2 BCL2 rearranged and 2 monoclonal for IgH) were considered false-positive on the basis of histologic features or clinical control </plain></SENT>
<SENT sid="6" pm="."><plain>These data indicate that the combined PCR analysis of IgH and BCL2 rearrangements can confirm a cytologic diagnosis of <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in FNAs while, due to the occurrence of both false-positive and false-negative results, it is of limited value in the distinction between follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:mp ids='MP_0000688'>lymphoid hyperplasia</z:mp> without morphologic or clinical support </plain></SENT>
</text></document>